Treating tobacco use and dependence in clinical practice

Expert Opinion on Pharmacotherapy

Volumn 7, Issue 6, 2006, Pages 783-792

  Cornuz, Jacques ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Nicotine replacement therapy; Prevention; Smoking; Smoking cessation; Tobacco

Indexed keywords

AMANTADINE; AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; BUSPIRONE; CARBAMAZEPINE; CLONIDINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LEVODOPA; LOBELINE; MECAMYLAMINE; METOPROLOL; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NALOXONE; NICOTINE DERIVATIVE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; RISPERIDONE; RITONAVIR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIORIDAZINE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ANGIONEUROTIC EDEMA; APPLICATION SITE BURNING; APPLICATION SITE IRRITATION; BONE PAIN; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COUGHING; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; GASTROINTESTINAL DISEASE; HICCUP; HUMAN; HYPNOSIS; INSOMNIA; META ANALYSIS; MOUTH DISEASE; MOUTH ULCER; NAUSEA; NICOTINE REPLACEMENT THERAPY; NOSE IRRITATION; PATIENT COUNSELING; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRURITUS; RELAPSE; REVIEW; RHINORRHEA; SEIZURE; SELF HELP; SIDE EFFECT; SKIN SENSITIVITY; SLEEP DISORDER; SMOKING CESSATION; SOCIAL SUPPORT; SORE THROAT; SYSTEMATIC REVIEW; THROAT IRRITATION; TOBACCO DEPENDENCE; TOOTH DISEASE; URTICARIA; WEIGHT GAIN; XEROSTOMIA;

HUMANS; PHYSICIAN'S ROLE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 33645835147     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.7.6.783     Document Type: Review

References (46)

1. US DEPARTMENT OF HEALTH AND HUMAN SERVICES: The health benefits of smoking cessation. A report of the Surgeon General, 1990. DHHS publication. Rockville: US Department of Health and Human Services (1990):CDC-90-8416.
2. EZZATI M, LOPEZ AD: Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 362:847.
3. DOLL R, PETO R, BOREHAM J et al.: Mortality in relation to smoking: 50 years' observation on male British doctors. Br. Med. J. (2004) 328:1519.
4. FIORE MC, BAILEY WC, COHEN SJ et al.: Treating tobacco use and dependence. Clinical practice guideline. Rockville: US Department of Health and Human Services. Public Health Service (2000).
5. THORNDIKE AN, RIGOTTI NA, STAFFORD RS, SINGER DE: National patterns in the treatment of smokers by physicians. JAMA (1998) 279:604-608.
6. RAW M, MCNEILL A, WEST R: Smoking cessation guidelines for health professionals. Thorax (1998) 53(Suppl.):S1-S19.
7. RIGOTTI N: Treatment of tobacco use and dependence. N. Engl. J. Med. (2002) 346:506-512.
8. US DEPARTMENT OF HEALTH AND HUMAN SERVICES: Reducing tobacco use: a report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2000).
9. LANCASTER T, STEAD L, SILAGY C et al.: Effectiveness of interventions to help people stop smoking: finding form the Cochrane Library. Br. Med. J. (2000) 321:355-358.
10. CORNUZ J, HUMAIR JP, SEEMATTER L et al.: Efficacy of resident training in smoking cessation training: a randomized controlled trial of a program based on application of behavioral therapy and practice with standardized patients. Ann. Intern. Med. (2002) 136:429-37.
11. KUNZE M. Maximizing help for dissonant smokers. Addiction (2000) 95(Suppl. 1):S13-S17.
12. ROSENGREN A, WILHELMSEN L, WEDEL H: Coronary heart-disease, cancer, and mortality in male middle-aged light smokers. J. Intern. Med. (1992) 231:357-362.
13. FAGERSTROM KO: Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration (2005) 72:216-220.
14. LAM W, SZE PC, SACKS HS, CHALMERS TC: Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet (1987) 2:27-30.
15. SILAGY C, LANCASTER T, STEAD L et al.: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. (2004) 3:CD000146.
16. RICHMOND RL, KEHOE L, DE ALMEIDA NETO AC: Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Heart (1997) 78:617-618.
17. WARING WS: The role of pharmacotherapy in assisting smoking cessation. Eur. J. Clin. Pharmacol. (2003) 59:351-356.
18. GREENLAND S, SATTERFIELD MH, LANES SF: A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf. (1998) 18:297-308.
19. SCHNEIDER NG, OLMSTEAD R, NILSSON F, MODY FV, FRANZON M, DOAN K: Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction (1996) 91(9):1293-1306.
20. WALLSTROM M, SAND L, NILSSON F, HIRSCH JM: The long-term effect of nicotine on the oral mucosa. Addiction (1999) 94:417-423.
21. JOSEPH AM, NORMAN SM, FERRY LH et al.: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N. Engl. J. Med. (1996) 335:1792-1798
22. BENOWITZ NL, GOURLAY SG: Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J. Am. Coll. Cardiol. (1997) 29:1422-1431.
23. HURT, RD, SACHS DP, GLOVER ED et al.: A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med. (1997) 337:1195-1202.
24. HOLM KJ, SPENCER CM: Bupropion: a review of its use in the management of smoking cessation. Drugs (2000) 59:1007-1024.
25. HUGHES JR, STEAD LF, LANCASTER T: Antidepressant for smoking cessation. Cochrane Database Syst. Rev. (2004) 18(4):CD000031.
26. JORENBY DE, LEISCHOW SJ, NIDES MA et al.: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. (1999) 340:685-691.
27. HURT RD, KROOK JE, CROGHAN IT et al.: Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J. Clin. Oncol. (2003) 21:914-920.
28. ZELLWEGER JP, BLAZIENE A, ASTBURY C, HIDER A, HOGUE S: Bupropion hydrochloride sustained release is an effective and well tolerated aid to smoking cessation in a healthcare professionals population - a multicountry study. Am. J. Health Behav. (2005) 23:12-16.
29. DUNNER DL, ZISOOK S, BILLOW AA, BATEY SR, JOHNSTON JA, ASCHER JA: A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J. Clin. Psychiatry (1998) 59:366-373.
30. BELSON MG KELLEY TR: Bupropion exposures: clinical manifestations and medical outcome. J. Emerg. Med. (2002) 23:223-230.
31. WAGENA EJ, KNIPSCHILD P, ZEEGERS MP: Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction (2005) 100(3):317-326.
32. WHITE AR, RAMPES H, ERNST E: Acunpuncture for smoking cessation. Cochrane Database Syst. Rev. (2002) 2:CD000009.
33. LANGE JH, KRUSE CG: Recent advances in CB1 cannabinoid receptor antagonists. Curr. Opin. Drug Discov. Devel. (2004) 7:498-506.
34. MAURER P, JENNINGS GT, WILLERS J et al.: A therapeuthic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity. Eur. J. Immunol. (2005) 35:2031-2040.
35. SCHWID SR, HIRVONEN MD, KEESEY RE: Nicotine effects on body weight: a regulatory perspective. Am. J. Clin. Nutr. (1992) 55:878-884.
36. SORENSON B, PECHACEK TF: Attitudes toward smoking cessation among men and women. J. Behav. Medicine (1987) 10:40-45.
37. PIRIE, PL, MCBRIDE CM, HELLERSTEDT W et al.: Smoking cessation in women concerned about weight. Am. J. Public Health (1992) 82:1238-1243.
38. TALCOTT GE, FIEDLER ER, PASCALE RW et al.: Is weight gain after smoking cessation inevitable? J. Consul. Clinical Psychol. (1995) 63:313-316.
39. KLESGES RC, KLESGES LM: Cigarette smoking as a dieting strategy in a university population. Int. J. Eat. Disord. (1988) 7:413-419.
40. SWAN GE, WARD, MM, CARMELLI D, JACK LM: Differential rates of relapse in subgroups of male and female smokers. J. Clin. Epidemiol. (1993) 46:1041-1053.
41. PIRKE KM, LAESSLE RG: Restrained eating. In: Obesity. Theory and Therapy. AJ Stunkard, TA Wadden (Eds), Raven Press, New York, NY, USA (1993):151-162.
42. PERKINS KA, MITCHELL SL, EPSTEIN LH: Physiological and subjective responses to food cues as a function of smoking abstinence and dietary restraints. Physiol. Behav. (1995) 58:373-378.
43. PERKINS KA, EPSTEIN LH, FONTE C, MITCHELL S, GROBE JE: Gender, dietary restraint, and smoking's influence on hunger and the reinforcing value of food. Physiol. Behav. (1995) 57:675-680.
44. IRVIN JE, BOWERS CA, CLINT A, DUNN ME, WANG MC. Efficacy of relapse prevention: a meta-analytic review. J. Consult. Clin. Psychol. (1999) 67:563-570.
45. CROMWELL J, BARTOSCH WJ, FIORE MC, HASSELBLAD V, BAKER T. Cost-effectiveness of the clinical practice recommendations in the AHCPR Guideline for Smoking Cessation. JAMA (1997) 78:574-575.
46. SCHWARZ B, HARTL H, RIEDER A, KUNZE M: Treatment of coronary risk factors by general practitioners in Austria. Acta Medica Austriaca (2001) 28(1):1-4.